The results revealed that SNHG17 was highly expressed in tumor tissues and positively correlated with the level of TAM markers CD163, CD206, and IL-10, implying that SNHG17 not only played an essential role in the malignant progression of PDAC but was also closely associated with TAMs. Here, CD163 is linked to neoplasm.